Join us for sushi and a discussion of tildrakizumab for psoriasis!

Presenter: Robert Greenberg, MD

Objective: Understand the clinical profile, treatment durability, and dosing schedule of Ilumya (tildrakizumab-asmn) for the management of moderate to severe plaque psoriasis.

To register, please RSVP here and go to hlxregister.com (Program ID 8GNNV6).